High-Dose Mitoxantrone + Melphalan (MITO/L-PAM) as Conditioning Regimen Supported by Peripheral Blood Progenitor Cell (PBPC) Autograft in 113 Lymphoma Patients: High Tolerability With Reversible Cardiotoxicity
Leukemia - United Kingdom
doi 10.1038/sj.leu.2402011
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2001
Authors
Publisher
Springer Science and Business Media LLC